Betta Pharmaceuticals Co., Ltd.

¥47.34As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300558Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (5.42%)
Div yield 0.32%
ROE 4.02%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.62
PE TTM 74.87
TSR TTM (16.53%)
Mkt cap ¥20.04B
ROIC 4.33%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥53
12.09%
(44.31%)
Hold 8|11|12|3|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.68
0.76
0.81
0.84
16.58%
28.79%
29.77%
37.30%
Revenue¥B
2.075
2.123
2.249
2.285
2.63%
7.32%
8.80%
8.64%
Peers (US$3.004B)
Cap (US$)
PE
3.103B
66.44x
Capital
TTM
5Y
10Y
Leveragex
0.735
0.109
0.095
EBIT/Intx
0.686
0.671
0.576
Own earn%
(24.06)
(290.54)
(173.98)
Sh yield%
32.45
32.56
31.61
Owners
Insiders/Inst%
7.13
21.45
Short interest%
4.06
SBC / revenue%
3.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
12–20
$1 testx
—
Incr. ROIC%
0